Fox Chase Cancer Center News

PHILADELPHIA (July 27, 2016) – Researchers at Fox Chase Cancer Center have found that BET inhibitors, drugs that block the function of BET bromodomain proteins in cancer cells, may have limited success as single agents in ovarian cancer due to reprogramming of the protein kinome, leading to drug resistance.

PHILADELPHIA (July 25, 2016) — Molly E. Collins, MD, has joined the department of hematology/oncology at Fox Chase Cancer Center, providing additional physician support for the Fox Chase Cancer Center – Temple University Hospital Pain and Palliative Care Program.

PHILADELPHIA (July 21, 2016) — Abhishek Aphale, MD, has been appointed Assistant Professor of Dermatology at Fox Chase Cancer Center. He specializes in Mohs surgery and reconstruction and cutaneous oncology.

PHILADELPHIA (July 15, 2016) — Rajeswari Nagarathinam, MD, has joined the department of pathology at Fox Chase Cancer Center, focusing on both surgical pathology and cytopathology.

PHILADELPHIA (July 6, 2016) – The protein coding gene ERC33-MYC has been identified as a target in pancreatic cancer by researchers from Fox Chase Cancer Center - Temple Health.

PHILADELPHIA (June 24, 2016) — Shuanzeng (Sam) Wei, MD, PhD, has joined the department of pathology at Fox Chase Cancer Center as an assistant professor, where he will specialize in surgical pathology and cytopathology.

PHILADELPHIA (June 24, 2016) — Philip A. Pancari, MD, has joined the department of hematology/oncology at Fox Chase Cancer Center, providing additional physician support for the Fox Chase Cancer Center–Temple University Hospital Bone Marrow Transplant (BMT) Program.

PHILADELPHIA (June 21, 2016) — Fox Chase Cancer Center, in partnership with the American Cancer Society and the U.S. Department of Health and Human Services, will host the Regional Summit for Region III on June 29th, in conjunction with the Cancer Moonshot Summit held at Howard University, Washington DC.